Integrin-mediated type II TGF-? receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.
Ontology highlight
ABSTRACT: Tubulointerstitial fibrosis underlies all forms of end-stage kidney disease. TGF-? mediates both the development and the progression of kidney fibrosis through binding and activation of the serine/threonine kinase type II TGF-? receptor (T?RII), which in turn promotes a T?RI-mediated SMAD-dependent fibrotic signaling cascade. Autophosphorylation of serine residues within T?RII is considered the principal regulatory mechanism of T?RII-induced signaling; however, there are 5 tyrosine residues within the cytoplasmic tail that could potentially mediate T?RII-dependent SMAD activation. Here, we determined that phosphorylation of tyrosines within the T?RII tail was essential for SMAD-dependent fibrotic signaling within cells of the kidney collecting duct. Conversely, the T cell protein tyrosine phosphatase (TCPTP) dephosphorylated T?RII tail tyrosine residues, resulting in inhibition of T?R-dependent fibrotic signaling. The collagen-binding receptor integrin ?1?1 was required for recruitment of TCPTP to the T?RII tail, as mice lacking this integrin exhibited impaired TCPTP-mediated tyrosine dephosphorylation of T?RII that led to severe fibrosis in a unilateral ureteral obstruction model of renal fibrosis. Together, these findings uncover a crosstalk between integrin ?1?1 and T?RII that is essential for T?RII-mediated SMAD activation and fibrotic signaling pathways.
SUBMITTER: Chen X
PROVIDER: S-EPMC4109532 | biostudies-literature | 2014 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA